{"id":"https://openalex.org/W3097558013","doi":"https://doi.org/10.1183/13993003.congress-2020.5042","title":"Categorization of asthma patients by Global Initiative for Asthma (GINA) 2018 guidelines using a US administrative claims database","display_name":"Categorization of asthma patients by Global Initiative for Asthma (GINA) 2018 guidelines using a US administrative claims database","publication_year":2020,"publication_date":"2020-09-07","ids":{"openalex":"https://openalex.org/W3097558013","doi":"https://doi.org/10.1183/13993003.congress-2020.5042","mag":"3097558013"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2020.5042","doi":"https://doi.org/10.1183/13993003.congress-2020.5042","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2020.5042","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Monitoring airway disease","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029849168","display_name":"Mario Castro","orcid":"https://orcid.org/0000-0001-6328-8994","observed_orcids":["https://orcid.org/0000-0001-6328-8994"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]},{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario Castro","raw_affiliation_strings":["Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, United States of America","institution_ids":["https://openalex.org/I146416000","https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111458756","display_name":"Marko A. Mychaskiw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marko A Mychaskiw","raw_affiliation_strings":["Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071868650","display_name":"Sangtaeck Lim","orcid":"https://orcid.org/0009-0005-7273-1202","observed_orcids":["https://orcid.org/0009-0005-7273-1202"]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sangtaeck Lim","raw_affiliation_strings":["Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044861254","display_name":"Randall W. Brown","orcid":"https://orcid.org/0000-0002-8093-991X","observed_orcids":["https://orcid.org/0000-0002-8093-991X"]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Randall Brown","raw_affiliation_strings":["Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091233269","display_name":"Susan Colilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Colilla","raw_affiliation_strings":["Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Branded Pharmaceutical Products R&D Inc, West Chester, United States of America","institution_ids":["https://openalex.org/I4210139373"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"5042","last_page":"5042"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12664","display_name":"Clinical practice guidelines implementation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/asthma-severity-classification","display_name":"asthma severity classification","score":0.7070000171661377},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/short-acting-beta-agonists","display_name":"short-acting beta2-agonists","score":0.8939999938011169},{"id":"https://openalex.org/keywords/controller-medications","display_name":"controller medications","score":0.6909999847412109},{"id":"https://openalex.org/keywords/guideline-adoption","display_name":"guideline adoption","score":0.7080000042915344},{"id":"https://openalex.org/keywords/administrative-claims-data","display_name":"administrative claims data","score":0.6899999976158142},{"id":"https://openalex.org/keywords/insurance-claims","display_name":"insurance claims","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9117727279663086},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.8020239472389221},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5527985692024231},{"id":"https://openalex.org/C2992755240","wikidata":"https://www.wikidata.org/wiki/Q1519812","display_name":"Health plan","level":3,"score":0.4434778094291687},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4320388436317444},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4312957525253296},{"id":"https://openalex.org/C2909082789","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma exacerbations","level":3,"score":0.4195299744606018},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3379407823085785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20948150753974915},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2020.5042","doi":"https://doi.org/10.1183/13993003.congress-2020.5042","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2020.5042","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Monitoring airway disease","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"},{"score":0.4000000059604645,"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3092804632","https://openalex.org/W6902233803","https://openalex.org/W4283522130","https://openalex.org/W2321556729","https://openalex.org/W4210341548","https://openalex.org/W4367184342","https://openalex.org/W2990124576","https://openalex.org/W3127418390","https://openalex.org/W4380683873","https://openalex.org/W4205695209"],"abstract_inverted_index":{"Introduction:":[0],"GINA":[1,30,149,153,168,204],"steps":[2],"are":[3],"defined":[4],"based":[5,33],"on":[6,34],"reliever":[7],"and":[8,41,86,93,135,199,206],"controller":[9],"medications":[10],"used":[11],"to":[12,22,63,83],"treat":[13],"asthma.":[14],"Administrative":[15,175],"claims":[16,58,176],"data":[17,59,177,191],"offer":[18,178],"a":[19,179],"novel":[20,180],"means":[21,181],"describe":[23,163],"the":[24,43,114,147,184],"distribution":[25],"of":[26,38,45,55,156,182,187],"asthma":[27,39,47,74,173],"patients":[28,106,157],"by":[29,167,203],"2018":[31,65],"step":[32,169,205],"their":[35],"real-world":[36,164],"use":[37,44,166],"medications,":[40],"assess":[42],"newer":[46],"treatments":[48],"such":[49],"as":[50,120,124,128,132,137],"biologics.":[51],"Methods:":[52],"Retrospective":[53],"analysis":[54],"IBM\u00aeWatson":[56],"MarketScan\u00ae":[57],"from":[60,80],"Jan":[61,81],"2015":[62],"Dec":[64,84],"was":[66,144],"conducted.":[67],"Patients":[68,96],"were":[69,101,111,118,158],"aged":[70],"\u226512":[71],"years,":[72],"had":[73],"diagnosis,":[75],"short-acting":[76],"beta-agonist":[77],"prescription":[78],"indexed":[79],"2016":[82],"2017,":[85],"1-year":[87],"continuous":[88],"insurance":[89],"plan":[90],"enrolment":[91],"pre-":[92],"post-index":[94],"date.":[95],"with":[97,107],"comorbid":[98],"respiratory":[99],"conditions":[100],"excluded.":[102],"Results:":[103],"Of":[104],"7,746,127":[105],"available":[108],"data,":[109],"579,955":[110],"included":[112],"in":[113,146],"analysis.":[115],"Overall,":[116],"54.3%":[117],"classified":[119],"Step":[121,125,129,133,138],"1,":[122],"14.6%":[123],"2,":[126],"10.2%":[127],"3,":[130],"20.5%":[131],"4":[134],"0.4%":[136],"5":[139],"(Table).":[140],"Average":[141],"patient":[142],"age":[143],"greater":[145],"higher":[148],"steps.":[150],"Across":[151],"all":[152],"steps,":[154],"62\u201366%":[155],"female.":[159],"Conclusions:":[160],"These":[161,190],"findings":[162],"medication":[165],"among":[170],"insured":[171],"US":[172],"patients.":[174],"assessing":[183],"practical":[185],"adoption":[186],"treatment":[188,208],"guidelines.":[189],"provide":[192],"framework":[193],"for":[194],"future":[195],"research":[196],"evaluating":[197],"clinical":[198],"health":[200],"resource":[201],"outcomes":[202],"evolving":[207],"strategies.":[209]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-11-09T00:00:00"}